03 November 2026
: Case report
[In Press] An Elderly Woman With a Presumed Giant Hepatic Chronic Expanding Hematoma Managed Conservatively With Imaging Surveillance
Challenging differential diagnosis, Unusual or unexpected effect of treatment, Rare disease
Takuya HiramotoDOI: 10.12659/AJCR.955025
Am J Case Rep In Press; DOI: 10.12659/AJCR.955025
Available online: 2026-11-03, In Press, Corrected Proof
Publication in the "In-Press" formula aims at speeding up the public availability of the pending manuscript while waiting for the final publication. The assigned DOI number is active and citable. The availability of the article in the Medline, PubMed and PMC databases as well as Web of Science will be obtained after the final publication according to the journal schedule
Abstract
BACKGROUND
Giant hepatic chronic expanding hematoma is a rare, benign liver condition in which blood forms a collection within the liver parenchyma or capsule that slowly increases in size for more than 1 month. Management may include biopsy to exclude malignancy and surgical resection, but imaging can identify the diagnostic features and monitor progression. This report describes the case of an older adult woman with a presumed giant hepatic chronic expanding hematoma managed conservatively with computed tomography (CT) imaging surveillance.
CASE REPORT
An 84-year-old woman admitted for acute heart failure had a giant hepatic mass detected incidentally on contrast-enhanced CT. The absence of arterial-phase hyperenhancement and normal serum tumor markers made hepatocellular carcinoma unlikely. Contrast-enhanced magnetic resonance imaging showed a right-lobe lesion measuring 13 × 14 × 17 cm with heterogeneous T1 and T2 signal intensities (mosaic sign) and no internal contrast enhancement, favoring chronic expanding hematoma, although primary hepatic sarcoma and sarcomatoid carcinoma could not be completely excluded. Considering her age, concurrent heart failure, and preference, she was managed conservatively with CT imaging surveillance. Non-contrast CT at 3, 6, 9, and 12 months showed an unchanged maximum axial diameter of 16 cm, and she remained free of abdominal symptoms or hepatic complications.
CONCLUSIONS
Conservative management with CT imaging surveillance can be an individualized option for an older adult patient at high procedural risk with a presumed giant hepatic chronic expanding hematoma showing characteristic imaging features. Because the diagnosis was not confirmed histologically, predefined triggers for intervention and continued surveillance are required.
Keywords: Liver Neoplasms; Hematoma
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954600
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954889
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954405
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953611
Most Viewed Current Articles
07 Dec 2021 : Case report
28,714,025
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
181,538
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
125,043
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
08 May 2026 : Case report
97,330
DOI :10.12659/AJCR.952158
Am J Case Rep 2026; 27:e952158






